Your browser doesn't support javascript.
loading
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
Fernández-Nogueira, Patricia; Mancino, Mario; Fuster, Gemma; López-Plana, Anna; Jauregui, Patricia; Almendro, Vanesa; Enreig, Estel; Menéndez, Silvia; Rojo, Federico; Noguera-Castells, Aleix; Bill, Anke; Gaither, L Alex; Serrano, Laia; Recalde-Percaz, Leire; Moragas, Núria; Alonso, Raul; Ametller, Elisabet; Rovira, Ana; Lluch, Ana; Albanell, Joan; Gascon, Pere; Bragado, Paloma.
Afiliação
  • Fernández-Nogueira P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Mancino M; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Fuster G; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • López-Plana A; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Jauregui P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Almendro V; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Enreig E; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Menéndez S; Division of Medical Oncology, Department of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.
  • Rojo F; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Noguera-Castells A; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Bill A; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Gaither LA; Pathology Department, CIBERONC- IIS-Fundación Jiménez Díaz, Madrid, Spain.
  • Serrano L; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Recalde-Percaz L; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Moragas N; Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts.
  • Alonso R; Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts.
  • Ametller E; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Rovira A; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Lluch A; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Albanell J; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Gascon P; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Bragado P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Clin Cancer Res ; 26(6): 1432-1448, 2020 03 15.
Article em En | MEDLINE | ID: mdl-31699826
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos / Fibroblastos Associados a Câncer / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos / Fibroblastos Associados a Câncer / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article